Evidence map›Paper›PMID 27288537›Full record

ArticleThe Journal of infectious diseases2016

Intrahost Evolution of Methicillin-Resistant Staphylococcus aureus USA300 Among Individuals With Reoccurring Skin and Soft-Tissue Infections.

Taj Azarian, Robert S Daum, Lindsay A Petty, Jenny L Steinbeck, Zachary Yin, David Nolan, Susan Boyle-Vavra, W P Hanage, Marco Salemi, Michael Z David

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Human Milk-DerivedMicroorganisms · 2024
    Article
  5. PNAS nexus · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Observational
  14. Genomic analyses ofMicrobial genomics · 2020
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Genome Plasticity ofInfection and immunity · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Taj AzarianCenter for Communicable Disease Dynamics, Department of Epidemiology, T. H. Chan School of Public Health, Harvard University, Boston, Massachusetts.
Robert S DaumDepartment of Pediatrics.
Lindsay A PettyDepartment of Medicine, University of Chicago, Illinois.
Jenny L SteinbeckDepartment of Medicine, University of Chicago, Illinois.
Zachary YinDepartment of Pediatrics.
David NolanDepartment of Pathology, Immunology, and Laboratory Medicine, College of Medicine Emerging Pathogens Institute, University of Florida, Gainesville.
Susan Boyle-VavraDepartment of Pediatrics.
W P HanageCenter for Communicable Disease Dynamics, Department of Epidemiology, T. H. Chan School of Public Health, Harvard University, Boston, Massachusetts.
Marco SalemiDepartment of Pathology, Immunology, and Laboratory Medicine, College of Medicine Emerging Pathogens Institute, University of Florida, Gainesville.
Michael Z DavidDepartment of Pediatrics Department of Medicine, University of Chicago, Illinois.

Funding

Ecological and genetic contributions to the spread of resistance in pneumococcusR01AI106786 · NIAID · HARVARD SCHOOL OF PUBLIC HEALTH · PI HANAGE, WILLIAM · 2013 to 2017
$3.1M
Recurrent MRSA Infections: A Study of Risk Factors and Molecular EpidemiologyK23AI095361 · NIAID · UNIVERSITY OF CHICAGO · PI DAVID, MICHAEL ZDENEK · 2011 to 2015
$633k
NIAID NIH HHS K23 AI095361NIAID NIH HHS R01 AI106786
6 · The paper itself

Abstract

backgroundMethicillin-resistant Staphylococcus aureus (MRSA) USA300 is the leading cause of MRSA infections in the United States and has caused an epidemic of skin and soft-tissue infections. Recurrent infections with USA300 MRSA are common, yet intrahost evolution during persistence on an individual has not been studied. This gap hinders the ability to clinically manage recurrent infections and reconstruct transmission networks.

methodsTo characterize bacterial intrahost evolution, we examined the clinical courses of 4 subjects with 3-6 recurrent USA300 MRSA infections, using patient clinical data, including antibiotic exposure history, and whole-genome sequencing and phylogenetic analysis of all available MRSA isolates (n = 29).

resultsAmong sequential isolates, we found variability in diversity, accumulation of mutations, and mobile genetic elements. Selection for antimicrobial-resistant populations was observed through both an increase in the number of plasmids conferring multidrug resistance and strain replacement by a resistant population. Two of 4 subjects had strain replacement with a genetically distinct USA300 MRSA population. DISCUSSIONS: During a 5-year period in 4 subjects, we identified development of antimicrobial resistance, intrahost evolution, and strain replacement among isolates from patients with recurrent MRSA infections. This calls into question the efficacy of decolonization to prevent recurrent infections and highlights the adaptive potential of USA300 and the need for effective sampling.

Indexed as

Evolution, MolecularGenotypeAdultAnti-Bacterial AgentsDrug Resistance, BacterialFemaleGenetic VariationGenome, BacterialHumansInfantMaleMethicillin-Resistant Staphylococcus aureusMiddle AgedPhylogenyPlasmidsProspective StudiesAnti-Bacterial Agentsantibiotic resistanceevolutionintrahostMRSAphylogeneticrecurrent infectionsskin and soft-tissue infectionsStaphylococcus aureusUSA300whole-genome sequencingwithin host

Identifiers

PMID27288537
PMCPMC4996148

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.